Unknown

Dataset Information

0

Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.


ABSTRACT: The antiviral activities of synthesized K?2-helix peptide, which was derived from the viral FLICE-like inhibitor protein (vFLIP) of Kaposi's sarcoma-associated herpesvirus (KSHV), against influenza A virus (IAV) were investigated in vitro and in vivo, and mechanisms of action were suggested. In addition to the robust autophagy activity of the K?2-helix peptide, the present study showed that treatment with the K?2 peptide fused with the TAT peptide significantly inhibited IAV replication and transmission. Moreover, TAT-K?2 peptide protected the mice, that were challenged with lethal doses of highly pathogenic influenza A H5N1 or H1N1 viruses. Mechanistically, we found that TAT-K?2 peptide destabilized the viral membranes, depending on their lipid composition of the viral envelop. In addition to IAV, the K?2 peptide inhibited infections with enveloped viruses, such as Vesicular Stomatitis Virus (VSV) and Respiratory Syncytial Virus (RSV), without cytotoxicity. These results suggest that TAT-K?2 peptide is a potential antiviral agent for controlling emerging or re-emerging enveloped viruses, particularly diverse subtypes of IAVs.

SUBMITTER: Moon HJ 

PROVIDER: S-EPMC5501782 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.

Moon Ho-Jin HJ   Nikapitiya Chamilani C   Lee Hyun-Cheol HC   Park Min-Eun ME   Kim Jae-Hoon JH   Kim Tae-Hwan TH   Yoon Ji-Eun JE   Cho Won-Kyung WK   Ma Jin Yeul JY   Kim Chul-Joong CJ   Jung Jae U JU   Lee Jong-Soo JS  

Scientific reports 20170707 1


The antiviral activities of synthesized Kα2-helix peptide, which was derived from the viral FLICE-like inhibitor protein (vFLIP) of Kaposi's sarcoma-associated herpesvirus (KSHV), against influenza A virus (IAV) were investigated in vitro and in vivo, and mechanisms of action were suggested. In addition to the robust autophagy activity of the Kα2-helix peptide, the present study showed that treatment with the Kα2 peptide fused with the TAT peptide significantly inhibited IAV replication and tran  ...[more]

Similar Datasets

| S-EPMC5955454 | biostudies-literature
| S-EPMC9438030 | biostudies-literature
| S-EPMC7354578 | biostudies-literature
| S-EPMC5388099 | biostudies-literature
| S-EPMC6387902 | biostudies-literature
| S-EPMC5996087 | biostudies-literature
| S-EPMC3048366 | biostudies-literature
| S-EPMC5540969 | biostudies-other
2012-05-29 | GSE27702 | GEO
| S-EPMC5849756 | biostudies-literature